Related Experiment Video
Updated: Aug 1, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Complement activation in patients with amebic liver abscess
1Liver Unit, School of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Insights
Complement system activation differs in amebic liver abscess (ALA) patients. Those recovering with medical treatment showed classical pathway activation, while those needing drainage involved both classical and alternative pathways.
Area of Science:
- Immunology
- Infectious Diseases
Background:
- Amebic liver abscess (ALA) is a significant global health concern.
- The role of the complement system in ALA pathogenesis is not fully understood.
Purpose of the Study:
- To investigate serum complement component levels in ALA patients.
- To correlate complement activation patterns with treatment outcomes.
Main Methods:
- Quantification of complement components (C1q, C4, C3, factor B, factor H, C3d) in ALA patient serum.
- Comparison of complement levels between patient groups and controls.
- Analysis of complement activation pathways based on component levels.
Main Results:
- Patients recovering with medical treatment (Group 1) showed normal or increased complement levels, suggesting classical pathway activation.
- Patients requiring abscess drainage (Group 2) exhibited diminished levels of C1q, C3, factor B, and factor H, indicating activation of both classical and alternative pathways.
- C3d levels correlated with serum albumin and SGOT in some patients.
Conclusions:
- Complement system activation patterns vary in ALA based on treatment and prognosis.
- The findings suggest a role for the complement system in the immunopathogenesis of ALA.
Abstract:
Serum or plasma concentrations of components of the classical (C1q, C4) and alternative (C3, factor B) pathways, regulatory protein factor H, and one of the C3 products of degradation, C3d, were determined in 19 patients with amebic liver abscess (ALA). Patients were divided into two groups. Thirteen patients that recovered under medical treatment who had a significantly shorter clinical course on admission (P less than 0.05) (group 1) exhibited either normal (C1q; C4; factor B; C3d) or increased levels of these components (C3, P less than 0.001; factor B, P less than 0.01). On the other hand, 16 patients that recovered after medical treatment and abscess drainage (group 2) exhibited significantly diminished serum levels of C1q (P less than 0.05), C3 (P less than 0.001), factor B (P less than 0.01) and factor H (P less than 0.05), and normal levels of C4, and C3d as compared to the control group. The relationships among the complement components studied were suggestive of activation of the complement system through the classical pathway in patients within group 1 and through both pathways in group 2. Sera of 3 out of the 5 patients who initially exhibited low plasma levels of C3d showed an increase during convalescence. Plasma levels of C3d were demonstrated to show a direct correlation with serum albumin and SGOT in this group of patients. Possible implications of the complement system in the immunopathogenesis of ALA are discussed.
Related Concept Videos
Complement System
Cryptococcal Meningitis
Amebiasis
Brain Abscess l: Introduction
Hepatic Encephalopathy

